MXCT
MaxCyte, Inc. · Healthcare
President and CEO Douglas Doerfler sold $75K of MaxCyte, Inc.
Sold$75,000
$5.00Price
15,000Shares
−4%Stake
What MXCT did after the filing
- The stock from Wed, Apr 12 close, $5.17
- −21.9%
- S&P 500, same days
- +0.7%
Measured over 30 trading days, to the May 24 close.
Traded Mon, Apr 10. Filed Wed, Apr 12, 12:37 PM ET, during the session. Returns use the Apr 12 close and the May 24 close. Not investment advice.